Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab-Reference-Cited by-同舟云学术

Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab

Published:2015-04-15 Issue:13 Volume:45 Page:1363-1367
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Ifuku Hideki¹,Kusumoto Shigeru²,Tanaka Yasuhito³,Totani Haruhito²,Ishida Takashi²,Okada Masaya⁴,Murakami Shuko³,Mizokami Masashi⁵,Ueda Ryuzo⁶,Iida Shinsuke²

Affiliation:

1. Department of Internal Medicine; Amagasaki Central Hospital; Hyogo Japan

2. Department of Hematology and Oncology; Nagoya City University Graduate School of Medical Sciences; Nagoya Japan

3. Department of Virology and Liver Unit; Nagoya City University Graduate School of Medical Sciences; Nagoya Japan

4. Division of Hematology, Department of Internal Medicine; Hyogo College of Medicine; Hyogo Japan

5. The Research Center for Hepatitis and Immunology; National Center for Global Health and Medicine; Ichikawa Japan

6. Department of Tumor Immunology; Aichi Medical University School of Medicine; Aichi Japan

Funder

Ministry of Health, Labor and Welfare of Japan

the Ministry of Education, Culture, Sports Science and Technology of Japan

Grant-in-Aid for Scientific Research

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12513/fullpdf

Reference34 articles.

1. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy;Yeo;J Clin Oncol,2004

2. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan;Umemura;Clin Infect Dis,2008

3. Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma;Kusumoto;Int J Hematol,2009

4. Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports;Evens;Ann Oncol,2011

5. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study;Lok;Gastroenterology,1991

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy;Hepatology Research;2024-05-21

2. Hepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins;MacSween's Pathology of the Liver;2024

3. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era;World Journal of Gastroenterology;2023-09-07

4. Low incidence of hepatitis B virus reactivation in patients with hematological malignancies receiving novel anticancer drugs: A report from a high epidemic area and literature review;Journal of Microbiology, Immunology and Infection;2023-08

5. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies;Clinical Microbiology and Infection;2022-10